The effect of 17β-estradiol on weight, blood glucose and plasma insulin levels in diabetic rats

Gynecological Endocrinology

Volumn 15, Issue 6, 2001, Pages 433-438

  Adeghate, E ^a   Ponery, A S ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

17 Estradiol; Blood glucose; Diabetes mellitus; Insulin; Rat; Streptozotocin; Weight

Indexed keywords

ESTRADIOL; GLUCOSE; INSULIN; STEROID HORMONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0035702378     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/713602981     Document Type: Article

References (20)

1. Effect of oral contraceptive steroid hormones on metabolic parameters of streptozotocin-induced diabetic rat
2. Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women
3. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus
4. Oral contraceptive use and glucose metabolism in a national sample of women in the United States
5. Short-term replacement therapy improves insulin resistance, lipid and fibrinolysis in postmenopausal women with NIDDM
6. Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus
7. Rapid insulinotropic effect of 17-beta-estradiol via a plasma membrane receptor
8. Coated charcoal immunoassay of insulin
9. Effect of subcutaneous pancreatic tissue transplants on streptozotocin-induced diabetes in rats. II. Endocrine and metabolic functions
10. Blood glucose and plasma insulin studies during three months' use of a low-estrogen type oral contraceptive
11. Oral contraception in diabetic women. A crossover study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception
12. Low dosage oral contraception in women with previous gestational diabetes
13. The desogestrel-ethinyl estradiol combination and overweight: Current data
14. Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use
15. Triphasic oral contraception: Metabolic effects in normal women and those with previous gestational diabetes
16. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism
17. Short-term effects of oestradiol benzoate in normal, hypophysectomized and alloxan-diabetic male rats